Drug vials The debate around COVID vaccine patent waivers has been simmering slowly since October 2020, but the debate has been heating up since President Biden announced that the US would support the patent waiver. (Photo: Shutterstock)

The world is beginning to feel like it is returning to something approximating normalcy. In the US, all adults are now eligible to receive the COVID-19 vaccine, and nearly 150 million have. The Biden administration blew past its prior inoculation targets (100, then 200 million doses in his first 100 days) and has called an even more ambitious shot for this summer: 70% of all adults receiving one shot by July 4th.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.